(IVQ-U) Invesque - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: USD • Type: Common Stock •
IVQ-U: Homes, Care, Housing, Properties, Estates, Facilities, Services
Invesque Inc. (TO:IVQ-U) is a North American healthcare real estate company specializing in seniors housing and care properties. Its diversified portfolio spans independent living, assisted living, memory care, skilled nursing, and transitional care facilities. The company also owns and operates seniors housing properties, complementing its real estate investments with management services tailored to the healthcare sector. Headquartered in Toronto, Canada, Invesque focuses on strategic acquisitions and operational efficiency to drive value in the growing healthcare real estate market.
From a technical perspective, IVQ-U is currently trading at $0.13, with a 20-day SMA of $0.12 and a 50-day SMA of $0.10. The 200-day SMA stands at $0.12, indicating a potential downtrend. Average volume over the past 20 days is 138,090 shares, with an ATR of $0.01, suggesting low volatility. On the fundamental side, the company has a market cap of $118.77M USD, with a P/B ratio of 4.03 and a P/S ratio of 0.67. The negative RoE of -59.10% reflects current financial challenges.
Additional Sources for IVQ-U Stock
IVQ-U Stock Overview
| Market Cap in USD | 110m |
| Sector | Real Estate |
| Industry | Real Estate Services |
| GiC Sub-Industry | Real Estate Operating Companies |
| IPO / Inception |
IVQ-U Stock Ratings
| Growth 5y | -92.5% |
| Fundamental | -15.4% |
| Dividend | 8.0% |
| Rel. Strength | -56.3 |
| Analysts | - |
| Fair Price Momentum | 0.11 USD |
| Fair Price DCF | 0.11 USD |
IVQ-U Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 32.0% |
IVQ-U Growth Ratios
| Growth Correlation 3m | 69.6% |
| Growth Correlation 12m | -70.8% |
| Growth Correlation 5y | -95.5% |
| CAGR 5y | -46.50% |
| CAGR/Max DD 5y | -0.48 |
| Sharpe Ratio 12m | -0.04 |
| Alpha | -54.59 |
| Beta | 1.478 |
| Volatility | 71.08% |
| Current Volume | 0.5k |
| Average Volume 20d | 29.8k |
As of April 04, 2025, the stock is trading at USD 0.12 with a total of 500 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -17.24%, over three months by +41.18% and over the past year by -52.00%.
Neither. Based on ValueRay Fundamental Analyses, Invesque is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IVQ-U as of April 2025 is 0.11. This means that IVQ-U is currently overvalued and has a potential downside of -8.33%.
Invesque has no consensus analysts rating.
According to ValueRays Forecast Model, IVQ-U Invesque will be worth about 0.1 in April 2026. The stock is currently trading at 0.12. This means that the stock has a potential downside of -8.33%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 7.5 | 6108.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.1 | -8.3% |